Your shopping cart is currently empty

LeuRS-IN-2 (Compound 9) acts as an inhibitor of Wolbachia Leucyl-tRNA synthetase (LeuRS) in the presence of adenosine monophosphate (AMP), exhibiting an EC50 value of 6 nM and effectively inhibiting the growth of pathogenic hosts. It forms an adenosine adduct to hinder protein synthesis and shows promise in studies aimed at developing new antimicrobial agents targeting microbial communities.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | LeuRS-IN-2 (Compound 9) acts as an inhibitor of Wolbachia Leucyl-tRNA synthetase (LeuRS) in the presence of adenosine monophosphate (AMP), exhibiting an EC50 value of 6 nM and effectively inhibiting the growth of pathogenic hosts. It forms an adenosine adduct to hinder protein synthesis and shows promise in studies aimed at developing new antimicrobial agents targeting microbial communities. |
| In vitro | LeuRS-IN-2 demonstrates effective translational functionality in the fibroblast efficacy model of Wolbachia infection with an EC50 value of 90 nM, utilized at a concentration of 9 μM over 7 days. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.